| Summary: | Objectives: This study aims to assess the feasibility of combined truncal endothermal ablation (ETA) and ultrasound-guided foam
sclerotherapy (UGFS) in a single treatment session and compare this technique to published re-intervention rates following truncal ablation
alone.
Patients and methods: The study was a retrospective data analysis of prospectively collected data. The patients had a preoperative US and
then Endothermal Ablation (ETA) with concomitant UGFS. The need for a secondary treatment, technical success, operation time, patient
satisfaction, complications, and recurrence were evaluated.
Results: The mean follow-up was 4.4±3.7 months. The technical success was achieved in all patients. Sixty-six (93%) of the patients did
not need further treatments. Five patients (7%) needed further interventions with repeated combined ETA and UGFS (n=1, 1.4%) and
sclerotherapy (n=4, 5.6%). These interventions did not increase the financial cost of treatment, compared to ETA alone.
Conclusion: Our study results suggest that one-stop dual therapy for the treatment of VV is associated with less need for further treatment,
compared to truncal ETA alone without increasing the treatment cost. [Turk J Vasc Surg 2020; 29(2.000): 90-4]
|
|---|
